Troxerutin
Indication
1. It is suitable for hemiplegia, aphasia, pre-myocardial infarction syndrome, arteriosclerosis, central retinitis, thrombophlebitis, varicose veins, edema caused by increased vascular permeability, etc. caused by cerebral thrombosis and cerebral embolism; 2. It is suitable for hemiplegia, aphasia, arteriosclerosis, pre-infarction syndrome, thrombophlebitis, varicose veins, chronic venous insufficiency, central retinitis, diabetic retinitis, and edema caused by increased vascular permeability, etc. caused by cerebral thrombosis; 3. Clinical application shows that this product has a wide range of application and good efficacy, especially for the treatment of occlusive cerebrovascular disease.
Packaging Specification
API (for oral use)
Manufacturer
Sichuan Xieli Pharmaceutical Co., Ltd.
-
Founded in:
1992-04-17 -
Address:
No. 588, Middle Section of Mudan Avenue, Tianpeng Town, Pengzhou City, Sichuan Province -
Tax NO.:
91510000621814779U -
Registered Funds:
15 million yuan -
Website:
-
Email: